Our office is required to submit this document and to share this information (2022 Identifying Information Law - Agency Report) with interested parties in the essence of being transparent. It provides the community an opportunity to review this information and become familiar with the practice.
The Identifying Information Law requires City agencies to submit biennial reports related to their collection, disclosure, and retention of identifying information.
The Identifying Information Law requires City agencies to submit comprehensive biennial agency reports (Form 3) related to their collection, disclosure, and retention of identifying information and their privacy protection practices.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Local Law 65 of 2019, requires the Department of Environmental Protection to make information about known lead water service lines available on the city's website, available via LeadFreeNYC.
The DDC FY'2022 Diversity and EEO Training Summary for the accountability for the culture, development, enhancement and equal treatment of compliances for all Agency employees.
Board response to Community board Identifying Information Law Report-discussing disclosures of information by who in the agency can and cannot disclose certain information, what types of information under what circumstances information can be disclosed included whether we have our owns specific proc
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.
Report including (1) the number of opioid antagonists available; (2) the number of staff trained to administer; (3) the number of instances during the quarter it was administered; and (4) the number of instances in which the patient responded to the administration of an opioid antagonist.